TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/21/2024
Back to search
Official data from USPTO
LONSURF
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LONSURF
ST13
US500000085742542Class
1, 5, 42
Filing
85742542
Registration
4438626
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
49
Latest update
12/21/2024
Trademark type
Word
Nice classes
1, 5, 42
Filing date
10/01/2012
Registration date
11/26/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/08/2023
Last transaction
12/21/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
03
Owner location
Tokyo, JP
Examiner
CASTRO, GIANCARLO
Law office
M10
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Co., Ltd.
Representatives
Dionne D. Heard Osha Bergman Watanabe & Burton LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Industrial chemicals; active chemical ingredients for use in the manufacture of pharmaceuticals for treating cancer; chemical additives for use in the manufacture of anti-cancer pharmaceuticals; excipients for use in the manufacture of anti-cancer pharmaceutical preparations; reagents for scientific or medical research use in the field of oncology
Class 5
Anti-cancer preparations; pharmaceutical preparations for the treatment of tumor ; chemical reagents for medical purposes in the field of oncology
Class 42
Drug discovery services in the field of oncology; product safety testing; technological research and development relating to the chemical and pharmaceutical industry in the field of oncology; medical and scientific researchconducting clinical trials in the field of anti-cancer drugs; pharmaceuticalclinical and medical research and development services in the field of anti-cancer drugs; pharmaceutical product evaluation in the field of anti-cancer drugs
Publications
History of USPTO decisions and trademark events.
49 publications found
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
12/21/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/21/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/21/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/21/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/21/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/16/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/16/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/16/2024
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/04/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/04/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/04/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/04/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/04/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/04/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/09/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/09/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/09/2024
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/08/2023
NA15
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
11/08/2023
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/08/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/08/2023
15AK
REGISTERED - SEC. 15 ACKNOWLEDGED
11/08/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/06/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
05/12/2023
E15R
TEAS SECTION 15 RECEIVED
05/12/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/26/2022
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
12/04/2019
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
12/04/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/04/2019
ES8R
TEAS SECTION 8 RECEIVED
11/11/2019
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
04/05/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/31/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
11/26/2013
PUBO
PUBLISHED FOR OPPOSITION
09/10/2013
NPUB
NOTICE OF PUBLICATION
08/21/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/06/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/05/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/05/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/05/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/29/2013
CNRT
NON-FINAL ACTION MAILED
01/31/2013
CNRT
NON-FINAL ACTION WRITTEN
01/30/2013
DOCK
ASSIGNED TO EXAMINER
01/29/2013
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
10/25/2012
ALIE
ASSIGNED TO LIE
10/24/2012
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
10/12/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/05/2012
NWAP
NEW APPLICATION ENTERED
10/04/2012
Continuous trademark protection
Get notified about every new filing that threatens LONSURF or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.